This inventor holds 26 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 13 EPO patents, primarily in Organic Compounds. Top assignees: Intra-Cellular Therapies, Inc., Microsoft Technology Licensing, LLC. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (2012 - 2017)
- Redmond, WA (US) (2017)
- Sammamish, WA (US) (2017)
- Highland Park, NJ (US) (2017 - 2019)
- New York, NJ (US) (2020)
Company Filing History:
24 out of 181 
2 out of 56,259 
Years Active: 2012-2020
Areas of Expertise:
Title: Innovator Spotlight: Jun Zhao - Pioneering Pharmaceutical Advancements in New York
Introduction: Jun Zhao is an esteemed inventor based in New York, NY, recognized for his contributions to the field of pharmaceuticals. With an impressive portfolio of 24 patents, Zhao continues to push the boundaries of scientific innovation, fostering advancements aimed at improving healthcare outcomes.
Latest Patents: Among Zhao's most notable inventions are two recent patents related to organic compounds. The first patent focuses on PDEI inhibitory compounds of Formula I, detailing processes for their production and their applications as pharmaceuticals, as well as compositions comprising these compounds. The second patent highlights novel pyridinoxy phenylpropanamines, along with their pharmaceutical compositions and methods of use. Notably, it involves therapeutic methods designed to penetrate the blood-brain barrier and regulate norepinephrine and serotonin transporters ('NET/SERT').
Career Highlights: Currently, Jun Zhao is a key innovator at Intra-Cellular Therapies, Inc., where he leads projects aimed at developing groundbreaking therapeutic solutions. His expertise and vision have played a significant role in advancing the company’s mission to enhance the lives of patients through innovative treatments.
Collaborations: Throughout his career, Zhao has collaborated with experts in the field, including notable coworkers like Peng Li and Lawrence P. Wennogle. This collaborative approach fosters a rich environment of shared knowledge and innovation, contributing to the success of their research endeavors.
Conclusion: With a robust portfolio of patents and a commitment to innovation, Jun Zhao stands out as a leading figure in pharmaceutical research. His contributions not only reflect his dedication to scientific excellence but also highlight the vital role of inventors in shaping the future of medicine. As he continues his work at Intra-Cellular Therapies, Inc., the impact of his inventions is anticipated to advance healthcare solutions for many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile